Mycord has taken the responsibility to redefine private umbilical cord banking by introducing Pool Banking. Mycord intends to provide much needed hope and security by building a pool of allogenic UCB units so that the best matched cord blood unit can be made available.

Elixcell through its extensive research, expertise and state-of-the-art infrastructure provides innovative therapy with pure, viable and potent stem cells isolated from the tissue of the umbilical cord

Diseases Treatable

Since hematopoietic stem-cells (HSCs) can transform into any type of blood cell, they are currently being used in the treatment of various blood cancers and disorders. These include:

Leukemias

Lymphomas/solid tumors

Myelodysplasias

Bone marrow failure syndrome

Hemoglobinopathies

Immune deficiencies

Metabolic storage disorders

Histiocytosis

Neutrophil disorders

EMERGING THERAPIES WITH CORD TISSUE STEM CELLS

Alzheimer’s Disease

Bone Fractures

Brain Injury

Burns

Cardiac Regeneration

Cerebral Palsy

Cystic Fibrosis

Diabetes

Heart Disease

Hearing Loss

Liver Failure

Multiple Sclerosis

Osteoarthritis

Parkinson’s Disease

Spinal Cord Injury

Stroke

Others

Page 1

Page 2

Page 3

Page 4

Page 5

Page 6

Page 7

As per Latest draft of “ National Guideline for stem cell Research “ published by the Apex regulatory body of cellular therapy in India ICMR guidelines 2013 and also ICMR draft guideline 2017 it is clearly mentioned

14.1. Banking of Umbilical Cord Blood

UCB is a rich source of CD34+ hematopoietic and mesenchymal (stromal) stemcells. Use of UCB derived HSCs for treatment of various haematological and immunological disorders is currently well established, particularly where an HLAmatched sibling is not available. However, there is a paucity of public funded UCBbanks in India. On the other hand several private UCB banks have come-up, thatengage themselves in promotional advertisements offering storage of cord bloodwith the promise of future therapeutic use. Such advertisements are oftenmisleading for the public and lack comprehensive and accurate information to theconsumer. So far there is no scientific basis for preservation of cord blood forfuture self-use and this practice therefore raises ethical and social concerns.